These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 14169411)

  • 1. THE CLINICAL SIGNIFICANCE OF LOW DEGREES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS.
    STEWART SM; CROFTON JW
    Am Rev Respir Dis; 1964 Jun; 89():811-29. PubMed ID: 14169411
    [No Abstract]   [Full Text] [Related]  

  • 2. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 3. SPECIFIC DRUG THERAPY IN PULMONARY TUBERCULOSIS: ILLUSTRATED BY CLINICAL, RADIOLOGICAL, BACTERIOLOGICAL AND PATHOLOGICAL OBSERVATIONS IN RESECTED PATIENTS.
    NESET G
    Acta Chir Scand Suppl; 1964; 20():SUPPL 335:1-94. PubMed ID: 14265539
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE PROBLEM OF PRIMARY RESISTANCE].
    KATONA L; LAKITS E; PALOS F
    Tuberk Tudobetegsegek; 1964 Apr; 17():111-4. PubMed ID: 14186511
    [No Abstract]   [Full Text] [Related]  

  • 5. TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.
    ZIERSKI M
    Tubercle; 1964 Jun; 45():96-100. PubMed ID: 14161919
    [No Abstract]   [Full Text] [Related]  

  • 6. PRIMARY DRUG RESISTANCE.
    SINGH B
    Acta Tuberc Pneumol Scand; 1964; 45():70-6. PubMed ID: 14209271
    [No Abstract]   [Full Text] [Related]  

  • 7. [PRIMARY BACTERIAL RESISTANCE].
    IANELLO JA
    Torax; 1963; 12():154-6. PubMed ID: 14158176
    [No Abstract]   [Full Text] [Related]  

  • 8. [On results of examination of drug resistant tubercle bacilli in the sputum before chemotherapy of tuberculosis. 2].
    NAITO M
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1962 Sep; 11():38-43. PubMed ID: 13937293
    [No Abstract]   [Full Text] [Related]  

  • 9. ALTERNATING REGIMENS OF STREPTOMYCIN-PYAZINAMIDE, ISONIAZID-PARA-AMINOSALICYLIC ACID AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA
    Am Rev Respir Dis; 1964 Aug; 90():262-5. PubMed ID: 14198672
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE FREQUENCY OF APPEARANCE AND MICROBIOLOGICAL CLASSIFICATION OF ATYPICAL ACID-FAST BACILLI CULTURED FROM PATIENT MATERIAL].
    ZDUNCZYNK PAWELEK H; BLITEK GOLC D; KOSTRZEWSKA K
    Gruzlica (1926); 1964 Jan; 32():11-22. PubMed ID: 14127495
    [No Abstract]   [Full Text] [Related]  

  • 11. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZIERSKI M; BEK E; SIWINSKA I; WOZNIAK S
    Gruzlica (1926); 1964 Feb; 32():97-105. PubMed ID: 14136693
    [No Abstract]   [Full Text] [Related]  

  • 12. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZAJACZKOWSKA J; JANCZY S; BURACZEWSKA M; KORLAKOWSKI J; ZYCH D; KRYCHNIAK W
    Gruzlica (1926); 1964 Feb; 32():89-95. PubMed ID: 14136692
    [No Abstract]   [Full Text] [Related]  

  • 13. PRIMARY DRUG RESISTANCE: A CONTINUING STUDY OF TUBERCLE BACILLI IN A VETERAN POPULATION WITHIN THE UNITED STATES. IV. FACTORS INFLUENCING THE OBSERVED FREQUENCY OF RESISTANCE.
    HOBBY GL; JOHNSON PM; CRAWFORD-GAGLIARDI L; GREETHAM L; LENERT TF
    Am Rev Respir Dis; 1965 Apr; 91():575-82. PubMed ID: 14263936
    [No Abstract]   [Full Text] [Related]  

  • 14. CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    MOODIE AS; SISTER AQUINAS ; FOORD RD
    Tubercle; 1964 Sep; 45():192-201. PubMed ID: 14227804
    [No Abstract]   [Full Text] [Related]  

  • 15. CULTIVATION OF ACID-FAST ORGANISMS FROM TUBERCULOUS PATIENTS AFTER PROLONGED AND INTENSIVE TREATMENT.
    DARZINS E; PUKITE A
    Am Rev Respir Dis; 1964 Feb; 89():277-9. PubMed ID: 14117690
    [No Abstract]   [Full Text] [Related]  

  • 16. A STUDY ON PRIMARILY DRUG-RESISTANT STRAINS OF TUBERCLE BACILLI IN SHANGHAI. THE INCIDENCE AND VIRULENCE OF THE RESISTANT BACILLI.
    CHENG TY; TSUI HP; TUNG C; CHEN TM; CHANG KS; LI TS
    Chin Med J; 1964 May; 83():316-8. PubMed ID: 14169964
    [No Abstract]   [Full Text] [Related]  

  • 17. A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.
    VELU S; DAWSON JJ; DEVADATTA S; FOX W; KULKARNI KG; MOHAN K; RAMAKRISHNAN CV; STOTT H
    Tubercle; 1964 Jun; 45():144-59. PubMed ID: 14161913
    [No Abstract]   [Full Text] [Related]  

  • 18. THE CLINICAL SIGNIFICANCE OF PRIMARY DRUG RESISTANCE IN TUBERCULOSIS AS JUDGED IN A MILITARY POPULATION, 1960-1963.
    LEDWITH JW
    Am Rev Respir Dis; 1964 Oct; 90():516-23. PubMed ID: 14221664
    [No Abstract]   [Full Text] [Related]  

  • 19. CHEMOTHERAPY OF PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
    GIUNIO N
    Tubercle; 1964 Sep; 45():202-4. PubMed ID: 14227805
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.